 "Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production")
A visit by a government panel to the facilities of Serum Institute of India (SII) and Bharat Biotech has put both the companies on an overdrive to raise capacities of Covid-19 vaccines, Covishield and Covaxin, respectively.
“The manufacturers were asked to come up with ‘innovative’ ways to ramp up capacities quickly as the domestic vaccine demand is on the rise,” said a member of the panel.
He added that this may include repurposing existing capacities or forging manufacturing tie-ups.
Both the vaccine makers had sought funds from the government to ramp up production.
Sources said SII
“The manufacturers were asked to come up with ‘innovative’ ways to ramp up capacities quickly as the domestic vaccine demand is on the rise,” said a member of the panel.
He added that this may include repurposing existing capacities or forging manufacturing tie-ups.
Both the vaccine makers had sought funds from the government to ramp up production.
Sources said SII
